Impact Factor
3.78
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
3.81
1,271 total citations
h5-index
34
h5 depth signal
Cited share
83.5%
298 of 357
Total citations
1,271
Citation footprint
Metric signal
3.72
External metric anchor
Self-citation
2.5%
32 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
China
481
United States
467
Canada
50
United Kingdom
41
Vietnam
40
Citing Fields of Research
Oncology
686
Breast Cancer
231
Liver & Colon Cancer
181
Lung Cancer
137
Palliative Care
115
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
2,953
Articles tracked across the journal lifetime
Indexed publication set
357
298 cited publications
Last 12 months
233
19.4 publications/month
Open access share
100.0%
233 OA publications in the last year
Leading citing country
China
481 citing publications
Leading citing field
Oncology
686 citing publications
Latest tracked publication
29 September 2026
10 recent records available
Coverage & Indexing History
v7n1, Jan./Feb. 2000-
v7n1, Jan./Feb. 2000-
Active Coverage
Active Coverage
Research Focus & Classification
Indexed Subjects
Oncology
Breast Cancer
Liver & Colon Cancer
Lung Cancer
Palliative Care
Issuing & Sponsoring Bodies
Contributor
H. Lee Moffitt Cancer Center and Research Institute
Broad Categories
Neoplasms
Breast Cancer
Oncology
Liver & Colon Cancer
Digestive Disorders
Lung Cancer
Immunology
MeSH Descriptors
Medical Oncology
Neoplasms
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1177/10732748261493412
Open DOI
Autoantibody Profiles of Immune Checkpoint Inhibitor-Associated Myasthenia and Myositis
Introduction: Immune checkpoint inhibitor (ICI)-associated myasthenia and myositis are rare, potentially life-threatening neuromuscular immune-related adverse events, but their serological spectrum remains incompletely characterized. Thi...
02
DOI 10.1177/10732748261491715
Open DOI
Communication as a Clinical Intervention: The Role of the Oncology Hospitalist in Primary Palliative Care
Introduction: Hospitalized patients with advanced cancer frequently experience high symptom burden, prognostic uncertainty, and complex decision-making needs. Although specialty palliative care improves patient-centered outcomes, access ...
03
DOI 10.1177/10732748261493127
Open DOI
The Impact of Aerobic Exercise on Circulating T-Cells and NK-Cells in Colorectal Cancer Survivors: A Secondary Analysis of a Randomized Trial
Introduction: Aerobic exercise improves disease-free and overall survival in patients with colorectal cancer. This study tested the hypothesis that a key mechanism of action underpinning these survival benefits relates to exercise-induce...
04
DOI 10.1177/10732748261494049
Open DOI
Awareness, Accessibility, Authenticity, and Appropriateness: Multilevel Determinants of Research Engagement Among Underrepresented AYA Cancer Survivors
Introduction: Adolescent and young adult (AYA) cancer survivors (ages 15–39 at diagnosis) who identify as sexual and gender minorities [SGM] and/or Black, Indigenous, and Persons of Color [BIPOC]) experience survivorship challenges compo...
05
DOI 10.1177/10732748261495568
Open DOI
The Clinical Impact of End-of-Consolidation Measurable Residual Disease in High-Risk Pediatric B-Cell Acute Lymphoblastic Leukemia
Introduction: Blinatumomab (BLINA) has improved event-free survival (EFS) and overall survival (OS) in pediatric patients with high-risk B-cell acute lymphoblastic leukemia (ALL) and has become an effective bridging therapy to hematopoie...
06
DOI 10.1177/10732748261493417
Open DOI
Microplastic Pollution and Risk of Cancer: A Prospective Study Based on UK Biobank
Introduction: Various industrial pollutants have been implicated in tumorigenesis. However, the cancer risk associated with microplastics, a pervasive environmental pollutant, remains poorly understood. This study aimed to evaluate the a...
07
DOI 10.1177/10732748261494041
Open DOI
State Disparities in Lung Cancer Screening Uptake Despite Facility Availability in the United States, 2024-2025: A Cross-Sectional Ecological Study
Introduction: Lung cancer screening (LCS) provides substantial advantages as a secondary prevention strategy, yet screening rates remain low, with notable regional disparities. Our cross-sectional ecological study examined the variations...
08
DOI 10.1177/10732748261494028
Open DOI
Experiences of Shared Decision Making for Cancer Screening Among Deaf, DeafBlind, and Hard of Hearing Adults Participating in an ASL-Using Community Health Navigator Program: Preliminary Findings From a Nested Qualitative Study
Introduction: Deaf, DeafBlind, and hard of hearing (DDBHH) adults using American Sign Language (ASL) face persistent disparities in cancer screening adherence, compounded by systemic communication barriers and documented deficits in shar...
09
10
DOI 10.1177/10732748261491707
Open DOI
Exploring Primary Care Interventions to Increase Lung, Breast, and Cervical Cancer Screening With Individuals Experiencing Marginalization: A Scoping Review
Introduction: Screening for lung, breast, and cervical cancer can reduce morbidity and mortality by enabling earlier detection and treatment. However, participation remains below target levels, particularly among individuals experiencing...
Bibliographical & Catalog Notes
Title from cover.
Provides 3 hours of Category I continuing medical education.
Print issues ceased with 2014?
Starting with 2021-, articles published as they are received and compiled into annual volume.
Also available online.
v. 4, no. 1 (Jan. 1997)20000302 Notice not published Printed on acid-free paper